20062020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020

Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab

Caccese, M., Barbot, M., Ceccato, F., Padovan, M., Gardiman, M. P., Fassan, M., Denaro, L., Emanuelli, E., D'Avella, D., Scaroni, C., Zagonel, V. & Lombardi, G., Feb 2020, In : Anti-Cancer Drugs. 31, 2, p. 199-204 6 p.

Research output: Contribution to journalArticle

2019

A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: Clinical benefit is a plausible end point?

Villani, V., Fabi, A., Tanzilli, A., Pasqualetti, F., Lombardi, G., Vidiri, A., Gonnelli, A., Molinari, A., Cantarella, M., Bellu, L., Terrenato, I., Carosi, M., Maschio, M., Telera, S. M., Carapella, C. M., Cognetti, F., Paiar, F., Zagonel, V. & Pace, A., May 1 2019, In : Future Oncology. 15, 15, p. 1717-1727 11 p.

Research output: Contribution to journalArticle

Capecitabine in advanced hepatocellular carcinoma: A multicenter experience

Pelizzaro, F., Sammarco, A., Dadduzio, V., Pastorelli, D., Giovanis, P., Soldà, C., Rizzato, M. D., Lombardi, G., Lonardi, S., Peserico, G., Imondi, A., Sartori, A., Maddalo, G. & Farinati, F., Dec 2019, In : Dig. Liver Dis.. 51, 12, p. 1713-1719 7 p.

Research output: Contribution to journalArticle

Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma

Zoccarato, M., Valeggia, S., Zuliani, L., Gastaldi, M., Mariotto, S., Franciotta, D., Ferrari, S., Lombardi, G., Zagonel, V., De Gaspari, P., Ermani, M., Signori, A., Pichiecchio, A., Giometto, B. & Manara, R., Aug 26 2019, In : Neuroradiology. 60, p. 853-860 8 p.

Research output: Contribution to journalArticle

Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma

Zoccarato, M., Valeggia, S., Zuliani, L., Gastaldi, M., Mariotto, S., Franciotta, D., Ferrari, S., Lombardi, G., Zagonel, V., De Gaspari, P., Ermani, M., Signori, A., Pichiecchio, A., Giometto, B. & Manara, R., Aug 26 2019, In : Neuroradiology. 60, p. 853-60 7 p.

Research output: Contribution to journalArticle

Glioblastoma in Elderly Patients: Current Management and Future Perspectives

Minniti, G., Lombardi, G. & Paolini, S., Mar 8 2019, In : Cancers. 11, 3, p. 1-16 16 p.

Research output: Contribution to journalArticle

Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155)

Caccese, M., Ceccato, F., Fassan, M., Fassina, A., Padovan, M., Mammi, I., Iacobone, M., Scaroni, C., Zagonel, V. & Lombardi, G., Feb 2019, In : Seminars in Oncology. 46, 1, p. 104-105 2 p.

Research output: Contribution to journalArticle

Molecular Evolution of IDH Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study

Draaisma, K., Chatzipli, A., Taphoorn, M., Kerkhof, M., Weyerbrock, A., Sanson, M., Hoeben, A., Lukacova, S., Lombardi, G., Leenstra, S., Hanse, M., Fleischeuer, R., Watts, C., McAbee, J., Angelopoulos, N., Gorlia, T., Golfinopoulos, V., Kros, J. M., Verhaak, R. G. W., Bours, V. & 4 others, van den Bent, M. J., McDermott, U., Robe, P. A. & French, P. J., Nov 19 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38, 1, p. 81-99 19 p.

Research output: Contribution to journalArticle

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

Lombardi, G., De Salvo, G. L., Brandes, A. A., Eoli, M., Rudà, R., Faedi, M., Lolli, I., Pace, A., Daniele, B., Pasqualetti, F., Rizzato, S., Bellu, L., Pambuku, A., Farina, M., Magni, G., Indraccolo, S., Gardiman, M. P., Soffietti, R. & Zagonel, V., Jan 2019, In : The Lancet. Oncology. 20, 1, p. 110-119 10 p.

Research output: Contribution to journalArticle

Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor

Ceccato, F., Lombardi, G., Albiger, N., Mazzai, L., Pambuku, A., Rolma, G., Zagonel, V. & Scaroni, C., Jun 2019, In : Anti-Cancer Drugs. 30, 5, p. 533-536 4 p.

Research output: Contribution to journalArticle

Validation of the Comprehensive Geriatric Assessment as a Predictor of Mortality in Elderly Glioblastoma Patients

Lombardi, G., Bergo, E., Caccese, M., Padovan, M., Bellu, L., Brunello, A. & Zagonel, V., Oct 9 2019, In : Cancers. 11, 10, p. 1-12 12 p., E1509.

Research output: Contribution to journalArticle

2018

A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma

Brandes, A. A., Gil-Gil, M., Saran, F., Carpentier, A. F., Nowak, A. K., Mason, W., Zagonel, V., Dubois, F., Finocchiaro, G., Fountzilas, G., Cernea, D. M., Chinot, O., Anghel, R., Ghiringhelli, F., Beauchesne, P., Lombardi, G., Franceschi, E., Makrutzki, M., Mpofu, C., Urban, H-J. & 1 others, Pichler, J., Sep 28 2018, In : The oncologist.

Research output: Contribution to journalArticle

Different Timing to Use Bevacizumab in Patients with Recurrent Glioblastoma: Early Versus Delayed Administration

Pasqualetti, F., Gonnelli, A., Molinari, A., Cantarella, M., Montrone, S., Cristaudo, A., Baldaccini, D., Mattioni, R., Delishaj, D., Mazzotti, V., Morganti, R., Cocuzza, P., Fabrini, M. G., Lombardi, G., Rudà, R., Soffietti, R. & Paiar, F., Oct 2018, In : Anticancer Research. 38, 10, p. 5877-5881 5 p.

Research output: Contribution to journalArticle

Discordance of IDH mutational status between lesions in an adult patient with multifocal glioma

Lombardi, G., Puppa, A. D., Gardiman, M. P., Rossi, S., Candiotto, C., Zanatta, L., Bertorelle, R., De Rossi, A., Fassan, M. & Zagonel, V., Jul 5 2018, In : Neuro-Oncology. 20, 8, p. 1142-1143 2 p.

Research output: Contribution to journalLetter

Early recognition of aggressive pituitary adenomas: a single-centre experience

Ceccato, F., Regazzo, D., Barbot, M., Denaro, L., Emanuelli, E., Borsetto, D., Rolma, G., Alessio, L., Gardiman, M. P., Lombardi, G., Albiger, N., D’Avella, D. & Scaroni, C., Jan 1 2018, In : Acta Neurochirurgica. 160, 1, p. 49-55 7 p.

Research output: Contribution to journalArticle

Genetic, epigenetic and immunologic profiling of MMR-deficient relapsed glioblastoma

Indraccolo, S., Lombardi, G., Fassan, M., Pasqualini, L., Giunco, S., Marcato, R., Gasparini, A., Candiotto, C., Nalio, S., Fiduccia, P., Fanelli, G. N., Pambuku, A., Della Puppa, A., D'Avella, D., Bonaldi, L., Gardiman, M. P., Bertorelle, R., De Rossi, A. & Zagonel, V., Dec 4 2018, In : Clinical Cancer Research.

Research output: Contribution to journalArticle

Good tolerability of maintenance temozolomide in glioblastoma patients after severe hematological toxicity during concomitant radiotherapy and temozolomide treatment: report of two cases

Lombardi, G., Caccese, M., Bellu, L., Pambuku, A., Bergo, E., Berti, F., Gardiman, M. P., Della Puppa, A., Denaro, L., Dal Pos, S. & Zagonel, V., Oct 2018, In : Anti-Cancer Drugs. 29, 9, p. 924-928 5 p.

Research output: Contribution to journalArticle

Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy

Pasqualetti, F., Orlandi, P., Simeon, V., Cantarella, M., Giuliani, D., Di Desidero, T., Gonnelli, A., Delishaj, D., Lombardi, G., Sechi, A., Sanson, M., Zagonel, V., Paiar, F., Danesi, R., Guarini, S. & Bocci, G., Feb 2018, In : Molecular Neurobiology. p. 1396-1404

Research output: Contribution to journalArticle

Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology

Pasqualetti, F., Pace, A., Gonnelli, A., Villani, V., Cantarella, M., Delishaj, D., Vivaldi, C., Molinari, A., Montrone, S., Pellerino, A., Franchino, F., Baldaccini, D., Lombardi, G., Lolli, I., Catania, F., Bazzoli, E., Morganti, R., Fabi, A., Zagonel, V., Bocci, G. & 4 others, Fabrini, M. G., Rudà, R., Soffietti, R. & Paiar, F., Dec 2018, In : American Journal of Clinical Oncology. 41, 12, p. 1272-1275 4 p.

Research output: Contribution to journalArticle

Temozolomide treatment of a malignant pheochromocytoma and an unresectable MAX-related paraganglioma

Ferrara, A. M., Lombardi, G., Pambuku, A., Meringolo, D., Bertorelle, R., Nardin, M., Schiavi, F., Iacobone, M., Opocher, G., Zagonel, V. & Zovato, S., Jan 1 2018, In : Anti-Cancer Drugs. 29, 1, p. 102-105 4 p.

Research output: Contribution to journalArticle

2017

Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management

Luck, S. E., Wieringa, J. W., Blazquez-Gamero, D., Henneke, P., Schuster, K., Butler, K., Capretti, M. G., Cilleruelo, M. J., Curtis, N., Garofoli, F., Heath, P., Iosifidis, E., Klein, N., Lombardi, G., Lyall, H., Nieminen, T., Pajkrt, D., Papaevangelou, V., Posfay-Barbe, K., Puhakka, L. & 8 others, Roilides, E., Rojo, P., Saavedra-Lozano, J., Shah, T., Sharland, M., Saxen, H., Vossen, A. C. T. M. & ESPID Congenital CMV Group Meeting, L. ., Dec 1 2017, In : Pediatric Infectious Disease Journal. 36, 12, p. 1205-1213 9 p.

Research output: Contribution to journalArticle

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study

Brandes, A. A., Finocchiaro, G., Zagonel, V., Reni, M., Fabi, A., Caserta, C., Tosoni, A., Eoli, M., Lombardi, G., Clavarezza, M., Paccapelo, A., Bartolini, S., Cirillo, L., Agati, R. & Franceschi, E., 2017, In : Oncotarget. 8, 33, p. 55575-55581 7 p.

Research output: Contribution to journalArticle

Effectiveness of antiangiogenic drugs in glioblastoma patients: A systematic review and meta-analysis of randomized clinical trials

Lombardi, G., Pambuku, A., Bellu, L., Farina, M., Della Puppa, A., Denaro, L. & Zagonel, V., Mar 1 2017, In : Critical Reviews in Oncology/Hematology. 111, p. 94-102 9 p.

Research output: Contribution to journalReview article

Elderly patients with glioblastoma: Where are we going?

Lombardi, G., Pambuku, A. & Zagonel, V., Aug 1 2017, In : Translational Cancer Research. 6, p. S1022-S1024

Research output: Contribution to journalEditorial

Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy

Pasqualetti, F., Orlandi, P., Simeon, V., Cantarella, M., Giuliani, D., Di Desidero, T., Gonnelli, A., Delishaj, D., Lombardi, G., Sechi, A., Sanson, M., Zagonel, V., Paiar, F., Danesi, R., Guarini, S. & Bocci, G., Feb 1 2017, In : Molecular Neurobiology.

Research output: Contribution to journalArticle

Outcome of patients affected by newly diagnosed glioblastoma undergoing surgery assisted by 5-aminolevulinic acid guided resection followed by BCNU wafers implantation: a 3-year follow-up

della Puppa, A., Lombardi, G., Rossetto, M., Rustemi, O., Berti, F., Cecchin, D., Gardiman, M. P., Rolma, G., Persano, L., Zagonel, V. & Scienza, R., Jan 2017, In : Journal of Neuro-Oncology. 131, 2, p. 331-40 10 p.

Research output: Contribution to journalArticle

2016

Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent Glioblastoma

Labussière, M., Cheneau, C., Prahst, C., Gállego Pérez-Larraya, J., Farina, P., Lombardi, G., Mokhtari, K., Rahimian, A., Delattre, J. Y., Eichmann, A. & Sanson, M., Jan 2 2016, In : Cancer Investigation. 34, 1, p. 39-44 6 p.

Research output: Contribution to journalArticle

Annexin 2A sustains glioblastoma cell dissemination and proliferation

Maule, F., Bresolin, S., Rampazzo, E., Boso, D., Della Puppa, A., Esposito, G., Porcù, E., Mitola, S., Lombardi, G., Accordi, B., Tumino, M., Basso, G. & Persano, L., 2016, In : Oncotarget. 7, 34, p. 54632-54649 18 p.

Research output: Contribution to journalArticle

AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Brandes, A., Finocchiaro, G., Zagonel, V., Reni, M., Caserta, C., Fabi, A., Clavarezza, M., Maiello, E., Eoli, M., Lombardi, G., Monteforte, M., Proietti, E., Agati, R., Eusebi, V. & Franceschi, E., Sep 1 2016, In : Neuro-Oncology. 18, 9, p. 1304-1312 9 p.

Research output: Contribution to journalArticle

AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Brandes, A. A., Finocchiaro, G., Zagonel, V., Reni, M., Caserta, C., Fabi, A., Clavarezza, M., Maiello, E., Eoli, M., Lombardi, G., Monteforte, M., Proietti, E., Agati, R., Eusebi, V. & Franceschi, E., Sep 1 2016, In : Neuro-Oncology. 18, 9, p. 1304-1312 9 p.

Research output: Contribution to journalArticle

AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Brandes, A., Finocchiaro, G., Zagonel, V., Reni, M., Caserta, C., Fabi, A., Clavarezza, M., Maiello, E., Eoli, M., Lombardi, G., Monteforte, M., Proietti, E., Agati, R., Eusebi, V. & Franceschi, E., Sep 1 2016, In : Neuro-Oncology. 18, 9, p. 1304-1312 9 p.

Research output: Contribution to journalArticle

AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Brandes, A., Finocchiaro, G., Zagonel, V., Reni, M., Caserta, C., Fabi, A., Clavarezza, M., Maiello, E., Eoli, M., Lombardi, G., Monteforte, M., Proietti, E., Agati, R., Eusebi, V. & Franceschi, E., Sep 1 2016, In : Neuro-Oncology. 18, 9, p. 1304-1312 9 p.

Research output: Contribution to journalArticle

Cognitive Rehabilitation in Patients with Gliomas and Other Brain Tumors: State of the Art

Bergo, E., Lombardi, G., Pambuku, A., Della Puppa, A., Bellu, L., D'avella, D. & Zagonel, V., 2016, In : BioMed Research International. 2016, 3041824.

Research output: Contribution to journalReview article

Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: A randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

Mazza, E. A., Brandes, A., Zanon, S., Eoli, M., Lombardi, G., Faedi, M., Franceschi, E. & Reni, M., Jan 1 2016, In : Cancer Chemotherapy and Pharmacology. 77, 1, p. 115-120 6 p.

Research output: Contribution to journalArticle

Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: A randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

Mazza, E. A., Brandes, A., Zanon, S., Eoli, M., Lombardi, G., Faedi, M., Franceschi, E. & Reni, M., Jan 1 2016, In : Cancer Chemotherapy and Pharmacology. 77, 1, p. 115-120 6 p.

Research output: Contribution to journalArticle

Intraperitoneal chemotherapy in patients pretreated for ovarian cancer matched with patients treated with parenteral chemotherapy

Nicoletto, M. O., Casarin, A., Baldoni, A., Rulli, E., Tasca, G., Baretta, Z., Artioli, G., Lombardi, G., Cappetta, A., Floriani, I., Randon, G., Valpione, S., Litta, P., Conte, P., Mocellin, S. & Aliberti, C., Dec 1 2016, In : Anticancer Research. 36, 12, p. 6541-6546 6 p.

Research output: Contribution to journalArticle

Intraperitoneal chemotherapy in patients pretreated for ovarian cancer matched with patients treated with parenteral chemotherapy

Nicoletto, M. O., Casarin, A., Baldoni, A., Rulli, E., Tasca, G., Baretta, Z., Artioli, G., Lombardi, G., Cappetta, A., Floriani, I., Randon, G., Valpione, S., Litta, P., Conte, P., Mocellin, S. & Aliberti, C., Dec 1 2016, In : Anticancer Research. 36, 12, p. 6541-6546 6 p.

Research output: Contribution to journalArticle

Surgery on motor area metastasis

Rossetto, M., Ciccarino, P., Lombardi, G., Rolma, G., Cecchin, D. & Della Puppa, A., Jan 1 2016, In : Neurosurgical Review. 39, 1, p. 71-78 8 p.

Research output: Contribution to journalArticle

Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas

Losa, M., Bogazzi, F., Cannavo, S., Ceccato, F., Curtò, L., De Marinis, L., Iacovazzo, D., Lombardi, G., Mantovani, G., Mazza, E., Minniti, G., Nizzoli, M., Reni, M. & Scaroni, C., Feb 1 2016, In : Journal of Neuro-Oncology. 126, 3, p. 519-525 7 p.

Research output: Contribution to journalArticle

Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas

Losa, M., Bogazzi, F., Cannavo, S., Ceccato, F., Curtò, L., De Marinis, L., Iacovazzo, D., Lombardi, G., Mantovani, G., Mazza, E. A., Minniti, G., Nizzoli, M., Reni, M. & Scaroni, C., Feb 1 2016, In : Journal of Neuro-Oncology. 126, 3, p. 519-525 7 p.

Research output: Contribution to journalArticle

Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas

Losa, M., Bogazzi, F., Cannavo, S., Ceccato, F., Curtò, L., De Marinis, L., Iacovazzo, D., Lombardi, G., Mantovani, G., Mazza, E. A., Minniti, G., Nizzoli, M., Reni, M. & Scaroni, C., Feb 1 2016, In : Journal of Neuro-Oncology. 126, 3, p. 519-525 7 p.

Research output: Contribution to journalArticle

Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas

Losa, M., Bogazzi, F., Cannavo, S., Ceccato, F., Curtò, L., De Marinis, L., Iacovazzo, D., Lombardi, G., Mantovani, G., Mazza, E. A., Minniti, G., Nizzoli, M., Reni, M. & Scaroni, C., Feb 1 2016, In : Journal of Neuro-Oncology. 126, 3, p. 519-525 7 p.

Research output: Contribution to journalArticle

The calm before the storm: A report from the International Liver Cancer Association Congress 2015 - Part 2

Cabibbo, G., Reig, M., Gadaleta-Caldarola, G., Galati, G., Lombardi, G., Mazza, G. C., Marzi, L., Saitta, C., Nault, J. C. & Sacco, R., Feb 1 2016, In : Future Oncology. 12, 3, p. 285-288 4 p.

Research output: Contribution to journalArticle

The calm before the storm: A report from the International Liver Cancer Association Congress 2015 - Part 1

Cabibbo, G., Reig, M., Gadaleta-Caldarola, G., Galati, G., Lombardi, G., Mazza, G. C., Marzi, L., Saitta, C., Nault, J. C. & Sacco, R., Feb 1 2016, In : Future Oncology. 12, 3, p. 281-284 4 p.

Research output: Contribution to journalArticle